Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 23

By: Newsfile

Dallas, Texas--(Newsfile Corp. - August 30, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q2 2023. The full report can be accessed by clicking on the following link: BPTH Q2 23 Report

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Prexigebersen reports positive interim results
  • $1.7M public offering closed in August
  • BP1001-A Phase 1 trials begin

Cannot view this image? Visit:

Click image above to view full announcement.

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.


Stonegate Capital Partners
(214) 987-4121

Source: Stonegate, Inc.

To view the source version of this press release, please visit

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.